Hepatic Artery Injection of (131)I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial

This prospective nonrandomized, multicenter clinical trial was performed to investigate the efficacy and safety of (131)I-labeled metuximab in adjuvant treatment of unresectable hepatocellular carcinoma. Methods: Patients were assigned to treatment with transcatheter arterial chemoembolization (TACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hui, Nan, Gang, Wei, Ding, Zhai, Ren-You, Huang, Ming, Yang, Wu-Wei, Xing, Bao-Cai, Zhu, Xu, Xu, Hai-Feng, Wang, Xiao-Dong, Zhang, Xiao-Yong, Zhu, Bao-Rang, Liu, Peng, Cao, Guang, Gao, Song, Hao, Chun-Yi, Yang, Ren-Jie, Guo, Jian-Hai, Zhang, Xin, Gao, Kun, Wang, Kun, Wang, Jian-Feng, Li, Zi-Yu, Zhu, Lin-Zhong, Ding, Rong, Li, Jing, Zhao, Ling, Shao, Yu-Jun, Liu, Hai-Chun, Xia, Jie-Lai, Wang, Ling, Kong, Ling-Min, Chen, Zhi-Nan, Bian, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973296/
https://www.ncbi.nlm.nih.gov/pubmed/34475235
http://dx.doi.org/10.2967/jnumed.121.262136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973296/
https://www.ncbi.nlm.nih.gov/pubmed/34475235
http://dx.doi.org/10.2967/jnumed.121.262136

Ejemplares similares